Ahead of the UNGASS 2016, senior representatives of several United Nations agencies have taken part in a high-level multi-stakeholder perspective in Geneva to discuss the intersections between public health, human rights and the world drug problem.
The legislation has created the first statewide licensing and operating rules for cannabis growers and retailers, prompting a divided reaction among advocates.
Speaking ahead of the World Hospice and Palliative Care Day, two United Nations human rights experts urge States and the international community to prioritise universal and non-discriminatory availability and access to palliative care and pain relief treatment to anyone in need.
The United Nations Office on Drugs and Crime, the agency that has overseen the global drug war for 50 years, has been blocked from announcing its momentous new position – that all countries should decriminalise the possession of drugs for personal use.
Drug Reporter's new movie provides an insight into the state of harm reduction in Eastern Europe: A struggle for survival in a time of economic austerity.
The drug trade is surprisingly resilient to the threat of capital punishment. Yet thousands of people languish on death row for drug-related crimes across Asia, Africa and the Middle East.
Speaking ahead of the 13th World Day Against the Death Penalty, observed on 10 October, UN experts agreed that "Executions for drug crimes amount to a violation of international law and are unlawful killing".
MEPs vote decisively in favour of the abolition of the death penalty for drug-related offences being made a prerequisite for EU financial and technical assistance to third countries.
Harm Reduction International is currently accepting tenders from capable, local partners to co-host the next International Harm Reduction Conference, to preferably be held in May/June of 2017.
The Congress ‘Drugs, Politics and culture: Perspectives from Brazil-Mexico’ (5th-6th October 2015) has concluded with a strong statement against the ‘unintended consequences’ of the current drug control regime.